1. ISBT 128 Implementation Plan for Cellular Therapy Products
- Author
-
Paul Ashford, Leigh Poston, Derwood Pamphilon, Pat Distler, Zbigniew M. Szczepiorkowski, Kathy Loper, Alan Lankester, Adrian P. Gee, Fran Rabe, Phyllis I. Warkentin, Ineke Slaper-Cortenbach, Irene Feller, and Stella Larsson
- Subjects
Quality Control ,medicine.medical_specialty ,Process management ,Traceability ,International Cooperation ,Immunology ,Transplants ,Plan (drawing) ,Product Labeling ,Terminology ,Consistency (database systems) ,ISBT 128 ,Humans ,Immunology and Allergy ,Medicine ,Blood Transfusion ,Project management ,Intensive care medicine ,Electronic Data Processing ,Medical Audit ,business.industry ,Administrative Personnel ,General Medicine ,Hematology ,Equipment and Supplies ,Practice Guidelines as Topic ,Blood Banks ,Guideline Adherence ,business ,Software - Abstract
The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics. J. Clin. Apheresis, 2007. © 2007 Internal Cellular Therapy Coding and Labeling Advisory Group.
- Published
- 2007
- Full Text
- View/download PDF